NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Grant MD, Marbella A, Wang AT, et al. Menopausal Symptoms: Comparative Effectiveness of Therapies [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Mar. (Comparative Effectiveness Reviews, No. 147.)
Vasomotor Symptoms
Table N-1
Vasomotor outcomes by age subgroups.
Table N-2
Vasomotor outcomes by BMI subgroups.
Table N-3
Vasomotor outcomes by race subgroups.
Table N-4
Vasomotor outcomes by severity of symptoms subgroups.
Table N-5
Vasomotor outcomes by time since menopause subgroups.
Table N-6
Vasomotor outcomes by uterus status subgroups.
Sexual Function
Table N-7
Sexual function outcomes by age subgroups.
Table N-8
Sexual function outcomes by BMI subgroups.
Table N-9
Sexual function outcomes by time since menopause subgroups.
Table N-10
Sexual function outcomes by uterus status subgroups.
Psychological Symptoms
Table N-11
Psychological outcomes by age subgroups.
Table N-12
Psychological outcomes by BMI subgroups.
Table N-13
Psychological outcomes by time since menopause subgroups.
Table N-14
Psychological outcomes by comorbidity subgroups.
Quality of Life
Table N-15
Quality of life outcomes for severity of symptom subgroups.
Table N-16
Quality of life outcomes for time since menopause subgroups.
Sleep Disturbance
Table N-17
Sleep disturbance outcomes by age subgroups.
Table N-18
Sleep disturbance outcomes by time since menopause.
Urogenital Atrophy
Table N-19
Urogenital outcomes by time since menopause subgroups.
- Effectiveness of Treatments for Menopausal Symptoms in Selected Subgroups - Meno...Effectiveness of Treatments for Menopausal Symptoms in Selected Subgroups - Menopausal Symptoms: Comparative Effectiveness of Therapies
- Evidence Tables for Sublingual Immunotherapy - Allergen-Specific Immunotherapy f...Evidence Tables for Sublingual Immunotherapy - Allergen-Specific Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and/or Asthma: Comparative Effectiveness Review
- Trichosporon inkin strain V23 internal transcribed spacer 1, partial sequence; 5...Trichosporon inkin strain V23 internal transcribed spacer 1, partial sequence; 5.8S ribosomal RNA gene, complete sequence; and internal transcribed spacer 2, partial sequencegi|1005506894|gb|KT900113.1|Nucleotide
- Trichosporon inkin strain V20 internal transcribed spacer 1, partial sequence; 5...Trichosporon inkin strain V20 internal transcribed spacer 1, partial sequence; 5.8S ribosomal RNA gene, complete sequence; and internal transcribed spacer 2, partial sequencegi|1005506893|gb|KT900112.1|Nucleotide
- MARVEL domain-containing protein [Caenorhabditis elegans]MARVEL domain-containing protein [Caenorhabditis elegans]gi|1767231513|ref|NP_001362014.1|Protein
Your browsing activity is empty.
Activity recording is turned off.
See more...